Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Enhertu
Pharma
Daiichi Sankyo spends €1B to bulk up in ADCs
Daiichi Sankyo is doubling down on its quest to rule the antibody-drug conjugate field with a €1 billion expansion set to create 350 new jobs.
Fraiser Kansteiner
Feb 20, 2024 9:50am
As AZ hits $45B revenue goal, is Enhertu nearing a plateau?
Feb 8, 2024 10:48am
Takeda, Lonza, US legislation—Fierce Pharma Asia
Feb 2, 2024 8:15am
Daiichi keeps dialing up Enhertu forecast, advances 2nd AZ ADC
Jan 31, 2024 3:42pm
Seagen patent invalidated in long-running Daiichi Sankyo spat
Jan 17, 2024 11:46am
Overall survival data blur Seagen's Tukysa-ADC path
Dec 6, 2023 8:15am